DE3752112D1 - Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen - Google Patents

Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen

Info

Publication number
DE3752112D1
DE3752112D1 DE3752112T DE3752112T DE3752112D1 DE 3752112 D1 DE3752112 D1 DE 3752112D1 DE 3752112 T DE3752112 T DE 3752112T DE 3752112 T DE3752112 T DE 3752112T DE 3752112 D1 DE3752112 D1 DE 3752112D1
Authority
DE
Germany
Prior art keywords
inositol triphosphate
treat inflammation
inositol
triphosphate
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3752112T
Other languages
English (en)
Other versions
DE3752112T2 (de
Inventor
Matti Siren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Publication of DE3752112D1 publication Critical patent/DE3752112D1/de
Application granted granted Critical
Publication of DE3752112T2 publication Critical patent/DE3752112T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
DE3752112T 1986-04-16 1987-04-15 Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen Expired - Fee Related DE3752112T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601709A SE465305B (sv) 1986-04-16 1986-04-16 Anvaendning av inositolfosfat foer framstaellning av ett laekemedel

Publications (2)

Publication Number Publication Date
DE3752112D1 true DE3752112D1 (de) 1997-10-02
DE3752112T2 DE3752112T2 (de) 1998-01-15

Family

ID=20364198

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3752112T Expired - Fee Related DE3752112T2 (de) 1986-04-16 1987-04-15 Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
DE3789576T Expired - Fee Related DE3789576T2 (de) 1986-04-16 1987-04-15 Verwendung von Inositol-Triphosphat zur Behandlung von Metallvergiftung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3789576T Expired - Fee Related DE3789576T2 (de) 1986-04-16 1987-04-15 Verwendung von Inositol-Triphosphat zur Behandlung von Metallvergiftung.

Country Status (7)

Country Link
US (1) US5019566A (de)
EP (2) EP0508488B1 (de)
JP (1) JP2528115B2 (de)
AT (1) ATE157251T1 (de)
DE (2) DE3752112T2 (de)
ES (2) ES2054628T3 (de)
SE (1) SE465305B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
JPH01287035A (ja) * 1988-05-13 1989-11-17 Sanwa Kagaku Kenkyusho Co Ltd 薬物並びにアルコール性中毒の予防剤とその治療剤
JPH01294730A (ja) * 1988-05-23 1989-11-28 Mitsubishi Kasei Vinyl Co ポリエステル系可塑剤
SE464059C (sv) * 1988-09-15 1996-12-04 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
CA2019878A1 (en) * 1989-09-13 1991-03-13 Robert Sabin Method of treatment of rheumatoid arthritis using phytic acid
JPH03115290A (ja) * 1989-09-28 1991-05-16 Yokohama Rubber Co Ltd:The １ｄ―ミオイノシトール―１―リン酸の合成法
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
US5827837A (en) * 1993-08-20 1998-10-27 The Regents Of The University Of California Polyanion anti-inflammatory agents
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
EP0728468A3 (de) 1995-02-26 2000-07-19 Unilever Plc Kosmetische Mittel zur Behandlung von Juckreiz
US5552148A (en) * 1995-06-07 1996-09-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly with inositol phosphates
US5614511A (en) * 1996-03-11 1997-03-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for treating itchy skin
US6949517B1 (en) * 1996-06-24 2005-09-27 Matti Siren Method of treating inflammatory, tissue repair and infectious conditions
SE9602463D0 (sv) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
US6221856B1 (en) 1999-02-03 2001-04-24 Inologic, Inc. Inositol derivatives for inhibiting superoxide anion production
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
AU2003231157C1 (en) 2002-04-29 2009-02-26 Normoxys, Inc. Inositol pyrophosphates, and methods of use thereof
FI20021570A0 (fi) * 2002-09-03 2002-09-03 Gallen Kallela Siren Janne Päällystetyn kirurgisen stentin paranneltu rakenne
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US7745423B2 (en) 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
ES2532591T3 (es) * 2005-03-18 2015-03-30 Normoxys, Inc. Sal de calcio y de sodio de mio-inositol 1,6:2,3:4,5 tripirofosfato para el tratamiento del cáncer
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
WO2008134082A1 (en) * 2007-05-01 2008-11-06 Oxyplus, Inc. Erythropoietin complementation or replacement

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723938A (en) * 1952-12-05 1955-11-15 Bristol Lab Inc Aqueous penicillin suspensions comprising inositol phosphoric acids and their salts
US3591665A (en) * 1967-09-08 1971-07-06 Mitsui Toatsu Chemicals Process for producing phytic acid
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
JPH0338824A (ja) * 1989-07-06 1991-02-19 Nec Corp 半導体細線の製造方法
JPH0354924A (ja) * 1989-07-24 1991-03-08 Alpine Electron Inc ダイバーシティラジオ受信機
JP3136659B2 (ja) * 1991-07-17 2001-02-19 松下電器産業株式会社 空気清浄器

Also Published As

Publication number Publication date
EP0508488A3 (de) 1992-10-28
DE3789576T2 (de) 1994-08-25
SE465305B (sv) 1991-08-26
EP0508488A2 (de) 1992-10-14
EP0508488B1 (de) 1997-08-27
EP0252227B1 (de) 1994-04-13
SE8601709D0 (sv) 1986-04-16
US5019566A (en) 1991-05-28
EP0252227A3 (en) 1990-10-10
SE8601709L (sv) 1987-10-17
JP2528115B2 (ja) 1996-08-28
ES2054628T3 (es) 1994-08-16
EP0252227A2 (de) 1988-01-13
DE3752112T2 (de) 1998-01-15
ES2106794T3 (es) 1997-11-16
ATE157251T1 (de) 1997-09-15
DE3789576D1 (de) 1994-05-19
JPS6310727A (ja) 1988-01-18

Similar Documents

Publication Publication Date Title
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
SE8504967D0 (sv) A pharmaceutical composition and a method of treating the body
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DE3781488D1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE131729T1 (de) 3,5-diiod-l-thyronin zur tsh-suppression und behandlung von struma
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE66375T1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
ES468750A1 (es) Un metodo para preparar una composicion veterinaria que com-prende trimetoprim y sulfaquinoxalina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee